Who are Oral prednisolone Taper's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): methylprednisolone PO, Prednisone Taper, Celestone + Celestone, phosphate and betamethasone acetate, 2 mL., Prednisone 6 weeks, Prednisone therapy and pharmacokinetic.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/oral-prednisolone-taper.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Oral prednisolone Taper — Competitive Intelligence Brief

Oral prednisolone Taper (Oral prednisolone Taper) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology / Rheumatology / General inflammation.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology / Rheumatology / General inflammation Small molecule Live · refreshed every 30 min

Target snapshot

Oral prednisolone Taper (Oral prednisolone Taper) — Berinstein, Jeffrey. Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Oral prednisolone Taper TARGET	Oral prednisolone Taper	Berinstein, Jeffrey	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
methylprednisolone PO	methylprednisolone PO	Rennes University Hospital	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Prednisone Taper	Prednisone Taper	Shilpa Grover, MD, MPH	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Celestone + Celestone	Celestone + Celestone	McMaster University	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
phosphate and betamethasone acetate, 2 mL.	phosphate and betamethasone acetate, 2 mL.	Hospital Italiano de Buenos Aires	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Prednisone 6 weeks	Prednisone 6 weeks	Xinqiao Hospital of Chongqing	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Prednisone therapy and pharmacokinetic	Prednisone therapy and pharmacokinetic	University Hospital, Caen	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
Astellas Pharma Inc · 2 drugs in this class
Sanofi · 2 drugs in this class
Xinqiao Hospital of Chongqing · 2 drugs in this class
Berinstein, Jeffrey · 2 drugs in this class
Ain Shams University · 2 drugs in this class
Children's Hospital of Philadelphia · 1 drug in this class
Celgene · 1 drug in this class
Hamilton Health Sciences Corporation · 1 drug in this class
Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oral prednisolone Taper — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-prednisolone-taper. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab